GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRIS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Curis stock price ended at $15.95 on Wednesday, after gaining 4.45%.
(Updated on Apr 17, 2024)

Buy or Hold candidate since Mar 27, 2024 Gain 46.73% PDF

The Curis stock price gained 4.45% on the last trading day (Wednesday, 17th Apr 2024), rising from $15.27 to $15.95. During the last trading day the stock fluctuated 4.58% from a day low at $15.49 to a day high of $16.20. The price has been going up and down for this period, and there has been a 19.03% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 14 thousand more shares were traded than the day before. In total, 36 thousand shares were bought and sold for approximately $582.08 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 37.78% during the next 3 months and, with a 90% probability hold a price between $17.00 and $24.00 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

CRIS Signals & Forecast

The Curis stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $15.40 and $12.05. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Curis has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 05, 2024, and so far it has fallen -5.06%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Curis stock

Curis finds support from accumulated volume at $15.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.710 between high and low, or 4.58%. For the last week, the stock has had daily average volatility of 7.65%.

Our recommended stop-loss: $15.19 (-4.77%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (CRIS) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Curis to open at $15.88, and during the day (based on 14 day Average True Range), to move between $14.82 and $17.08, which gives a possible trading interval of +/-$1.13 (+/-7.06%) up or down from last closing price. If Curis takes out the full calculated possible swing range there will be an estimated 14.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $16.01 (0.38%) than the support at $15.58 (2.32%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Curis stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Curis stock to perform well in the short-term.

Current score: 4.287 Buy Candidate Unchanged

Predicted Opening Price for Curis of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$15.88 ( 0.439%) $15.95

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRIS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.59 4.01 %
R2 16.32 2.31 %
R1 16.15 1.26 %
Current price: 15.95
Support S1 15.61 -2.14 %
S2 15.44 -3.19 %
S3 15.17 -4.89 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 16.80 5.33 %
R2 16.50 3.45 %
R1 16.01 0.376 %
Current price 15.95
Support S1 15.58 -2.32%
S2 12.68 -20.50%
S3 12.32 -22.76%

FAQ

What is the symbol for Curis Stock and on which exchange is it traded?
The symbol for Curis is CRIS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Curis Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Curis stock to perform well in the short-term.

How to buy Curis Stock?
Curis Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Curis Stock.

What's the current price of Curis Stock?
As of the end of day on the 2024-04-17, the price of an Curis (CRIS) share was $15.95.

What is the 52-week high and low for Curis Stock?
The 52-week high for Curis Stock is $17.49 and the 52-week low is $0.380.

What is the market capitalization of Curis Stock?
As of the 2024-04-17, the market capitalization of Curis is 94.011M.

When is the next earnings date for Curis?
The upcoming earnings date for Curis is May 02, 2024.
Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT